| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.36 | 0.07 |